Related Experiment Video
Updated: Oct 11, 2025

Adapting Gastrointestinal Organoids for Pathogen Infection and Single Cell Sequencing under Biosafety Level 3 BSL-3 Conditions
Published on: September 10, 2021
Single-cell RNA analysis reveals the potential risk of organ-specific cell types vulnerable to SARS-CoV-2 infections
Zilong Zhang1, Feifei Cui1, Chen Cao2
1Institute of Fundamental and Frontier Sciences, University of Electronic Science and Technology of China, Chengdu, 610054, China; Yangtze Delta Region Institute (Quzhou), University of Electronic Science and Technology of China, Quzhou, 324000, China.
Abstract:
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic of coronavirus disease 2019 (COVID-19) since December 2019 that has led to more than 160 million confirmed cases, including 3.3 million deaths. To understand the mechanism by which SARS-CoV-2 invades human cells and reveal organ-specific susceptible cell types for COVID-19, we conducted comprehensive bioinformatic analysis using public single-cell RNA sequencing datasets. Utilizing the expression information of six confirmed COVID-19 receptors (ACE2, TMPRSS2, NRP1, AXL, FURIN and CTSL), we demonstrated that macrophages are the most likely cells that may be associated with SARS-CoV-2 pathogenesis in lung. Besides the widely reported 'chemokine storm', we identified ribosome related pathways that may also be potential therapeutic target for COVID-19 lung infection patients. Moreover, cell-cell communication analysis and trajectory analysis revealed that M1-like macrophages showed the highest relation to severe COVID-19 patients. And we also demonstrated that up-regulation of chemokine pathways generally lead to severe symptoms, while down-regulation of ribosome and RNA activity related pathways are more likely to be mild. Other organ-specific susceptible cell type analyses could also provide potential targets for COVID-19 therapy. This work can provide clues for understanding the pathogenesis of COVID-19 and contribute to understanding the mechanism by which SARS-CoV-2 invades human cells.
Insights
Macrophages are key in COVID-19 lung infections, with M1-like macrophages linked to severe disease. Ribosome pathways offer potential therapeutic targets for coronavirus disease 2019 (COVID-19) lung infections.
Area of Science:
- Immunology
- Virology
- Bioinformatics
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, has resulted in millions of deaths globally.
- Understanding SARS-CoV-2 cell invasion mechanisms and susceptible cell types is crucial for developing effective therapies.
Purpose of the Study:
- To identify organ-specific susceptible cell types for COVID-19 using bioinformatic analysis.
- To elucidate the role of specific cell types and pathways in COVID-19 pathogenesis and disease severity.
Main Methods:
- Comprehensive bioinformatic analysis of public single-cell RNA sequencing datasets.
- Utilized expression data for six confirmed COVID-19 receptors (ACE2, TMPRSS2, NRP1, AXL, FURIN, CTSL).
- Performed cell-cell communication and trajectory analyses.
Main Results:
- Macrophages identified as highly susceptible cells in lung pathogenesis of SARS-CoV-2.
- Ribosome-related pathways identified as potential therapeutic targets, alongside the "chemokine storm."
- M1-like macrophages showed the strongest association with severe COVID-19; chemokine pathways linked to severe symptoms, while ribosome/RNA pathways linked to mild symptoms.
Conclusions:
- Macrophages, particularly M1-like subtypes, play a significant role in COVID-19 lung pathogenesis and disease severity.
- Ribosome and RNA activity pathways represent novel therapeutic targets for COVID-19 lung infections.
- Bioinformatic analysis of susceptible cell types provides insights into COVID-19 mechanisms and potential therapeutic strategies.
More Related Videos
13:13Single-cell Quantitation of mRNA and Surface Protein Expression in Simian Immunodeficiency Virus-infected CD4+ T Cells Isolated from Rhesus macaques
Published on: September 25, 2018
05:23Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
Published on: December 23, 2020